With two billion people overweight or obese and the obesity treatment market expected to reach $200 billion by 2031, Olio ...

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...

A generic cancer drug is reportedly responsible for children with autism showing "drastic improvement," the New York Post ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

AstraZeneca acquired the hypoparathyroidism therapy eneboparatide as part of a buyout of Amolyt Pharma in July 2024.

YOU could soon grow your own Ozempic-like weight loss medication at home, scientists claim. A team of students from Canada ...

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

A basic tenet of receptor pharmacology is that a drug’s effect is directly proportional to the number of occupied receptors. Also, the duration of the drug effect is related to the association ...